Learn About the Law
Get help with your legal needs
FindLaw’s Learn About the Law features thousands of informational articles to help you understand your options. And if you’re ready to hire an attorney, find one in your area who can help.
IN RE: Michal KUNZ MD etc., Petitioner–Respondent, v. R.J., Respondent–Appellant.
Order, Supreme Court, New York County (W. Franc Perry III, J.), entered April 1, 2025, which, after a hearing, granted petitioner's application for the administration of anti-psychotic and mood-stabilizing medications to respondent for a period of one year, unanimously affirmed, without costs.
Although the order under appeal expired by its terms upon respondent's discharge from petitioner psychiatric center, we find that this appeal falls within the mootness exception doctrine because there is a likelihood of repetition, it is an occurrence typically evading review, and it involves substantial issues (see Matter of Lucas QQ. [Rahman], 146 AD3d 92, 95 [3d Dept 2016] ).
Petitioner met its burden of establishing by clear and convincing evidence that respondent lacks “the capacity to make a reasoned decision with respect to [the] proposed treatment” (Rivers v. Katz, 67 N.Y.2d 485, 497 [1986] ). Petitioner's evidence demonstrated that respondent suffered from “delusional disorder mixed state” (paranoia and grandiosity), an unrebutted psychiatric diagnosis of a presently existing psychotic disorder that was directly related to respondent's capacity to reason and whose symptoms grew worse when not on medication, and that respondent lacked insight regarding his mental illness (see Matter of Maldonado v. R.J., 93 AD3d 465, 466 [1st Dept 2012]; Matter of William S., 31 AD3d 567, 568 [2d Dept 2006] ). Petitioner further established, based on the testimony of the treating physician and respondent's hearing testimony, that respondent did not believe that he suffered from a mental illness or needed medication for his mental illness, which highlighted his inability to fully appreciate his diagnosis and his lack of capacity to assess his need for medication (see Matter of Walawender v. Antonio T., 236 AD3d 1389, 1390 [4th Dept 2025], lv dismissed 44 NY3d 1071 [2026]; Matter of Schlee [Clarence E.], 194 AD3d 1365, 1366 [4th Dept 2021] ).
The uncontroverted expert testimony concerning the proposed one-year treatment plan that detailed the medications, their dosages, and frequencies, also established by clear and convincing evidence that the plan was “narrowly tailored to give substantive effect to [respondent's] liberty interest” (Rivers, 67 N.Y.2d at 497). The record shows that all relevant circumstances were considered, “including [respondent's] best interests, the benefits to be gained from the treatment, the adverse side effects associated with the treatment,” and the alternative treatments (id. at 497–498; see Matter of Dill v. Jose P., 236 AD3d 1378, 1379 [4th Dept 2025]; Matter of Schlee, 194 AD3d at 1366; Matter of Pison B. [Raleigh B.], 163 AD3d 660 [2d Dept 2018] ).
We have considered respondent's remaining arguments and find them unavailing.
Thank you for your feedback!
As the largest network of trusted legal brands, we help firms build authority across the platforms consumers and AI systems rely on most. Our network helps attorneys strengthen visibility, credibility, and preference where legal decisions begin.
Docket No: Index No. 530065 /16
Decided: March 26, 2026
Court: Supreme Court, Appellate Division, First Department, New York.
Search our directory by legal issue
Enter information in one or both fields (Required)
Harness the power of our directory with your own profile. Select the button below to sign up.
Learn more about FindLaw’s newsletters, including our terms of use and privacy policy.
Get help with your legal needs
FindLaw’s Learn About the Law features thousands of informational articles to help you understand your options. And if you’re ready to hire an attorney, find one in your area who can help.
Search our directory by legal issue
Enter information in one or both fields (Required)